当前位置:首页 - 行情中心 - 国邦医药(605507) - 财务分析 - 现金流量表

国邦医药

(605507)

  

流通市值:125.06亿  总市值:125.06亿
流通股本:5.59亿   总股本:5.59亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,074,684,487.884,518,457,388.913,548,798,584.272,357,214,060.33
  收到的税费返还54,839,460.24174,583,174.26128,316,189.9580,357,131.15
  收到其他与经营活动有关的现金15,289,350.8687,228,732.2666,925,845.556,242,913.19
  经营活动现金流入小计1,144,813,298.984,780,269,295.433,744,040,619.722,493,814,104.67
  购买商品、接受劳务支付的现金627,595,780.073,042,877,825.082,453,822,341.51,795,171,004.8
  支付给职工以及为职工支付的现金208,921,982.15638,152,231.21490,575,169.08327,760,147
  支付的各项税费61,074,436.51236,343,718.61195,722,975.86140,537,743.75
  支付其他与经营活动有关的现金54,044,578.17303,617,360.95198,409,764.58127,468,322.52
  经营活动现金流出小计951,636,776.94,220,991,135.853,338,530,251.022,390,937,218.07
  经营活动产生的现金流量净额193,176,522.08559,278,159.58405,510,368.7102,876,886.6
二、投资活动产生的现金流量:
  收回投资收到的现金3,381,307,277.0215,367,860,342.3511,204,886,910.377,885,644,647.39
  取得投资收益收到的现金1,922,655.44877,682.412,908,614.84,275,341.24
  处置固定资产、无形资产和其他长期资产收回的现金净额-24,102,978.1517,391,741.167,000
  投资活动现金流入小计3,383,229,932.4615,392,841,002.911,235,187,266.337,889,926,988.63
  购建固定资产、无形资产和其他长期资产支付的现金91,488,235.6277,711,058.05267,111,860.66156,529,256.82
  投资支付的现金3,385,000,00015,966,588,846.3911,480,494,000.277,960,494,000.27
  投资活动现金流出小计3,476,488,235.616,244,299,904.4411,747,605,860.938,117,023,257.09
  投资活动产生的现金流量净额-93,258,303.14-851,458,901.54-512,418,594.6-227,096,268.46
三、筹资活动产生的现金流量:
  取得借款收到的现金325,000,0001,032,026,321.89912,045,385.23846,045,385.23
  收到其他与筹资活动有关的现金-184,579,636.56--
  筹资活动现金流入小计325,000,0001,216,605,958.45912,045,385.23846,045,385.23
  偿还债务支付的现金272,100,000813,790,675727,697,125.14633,662,888.89
  分配股利、利润或偿付利息支付的现金6,806,260.44359,627,313.46349,819,137.69344,835,327.45
  支付其他与筹资活动有关的现金-166,135,966.05109,651,422.94109,651,422.94
  筹资活动现金流出小计278,906,260.441,339,553,954.511,187,167,685.771,088,149,639.28
  筹资活动产生的现金流量净额46,093,739.56-122,947,996.06-275,122,300.54-242,104,254.05
四、汇率变动对现金及现金等价物的影响-7,741,059.84-1,358,562.083,233,366.234,476,304.15
五、现金及现金等价物净增加额138,270,898.66-416,487,300.1-378,797,160.21-361,847,331.76
  加:期初现金及现金等价物余额1,117,884,263.741,534,371,563.841,534,371,563.841,534,371,563.84
  期末现金及现金等价物余额1,256,155,162.41,117,884,263.741,155,574,403.631,172,524,232.08
补充资料:
  净利润-817,573,712.5-453,993,510.87
  资产减值准备-27,022,156.04-5,687,697.17
  固定资产和投资性房地产折旧-466,523,416.16-230,242,062.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-462,618,145.04-230,242,062.94
    投资性房地产折旧-3,905,271.12--
  无形资产摊销-11,095,559.27-5,446,297.32
  长期待摊费用摊销-469,989.72-234,994.86
  处置固定资产、无形资产和其他长期资产的损失--24,812,057.81-453,560.93
  固定资产报废损失-7,668,385.37-1,207,798.27
  公允价值变动损失--12,922,936.6--8,941,286.24
  财务费用-24,493,405.36-20,608,127.14
  投资损失--16,992,661.8--3,963,177.2
  递延所得税--7,811,431.25--4,177,204.33
  其中:递延所得税资产减少--4,558,529.52--3,570,285.87
    递延所得税负债增加--3,252,901.73--606,918.46
  存货的减少--439,762,402.05--126,321,351.77
  经营性应收项目的减少-258,279,703.95--357,735,423.44
  经营性应付项目的增加--562,844,945.01--126,929,146.53
  其他-6,354,189.82-4,736,965.32
  现金的期末余额-1,117,884,263.74-1,172,524,232.08
  减:现金的期初余额-1,534,371,563.84-1,534,371,563.84
  现金及现金等价物的净增加额--416,487,300.1--361,847,331.76
公告日期2026-04-162026-03-282025-10-172025-07-30
审计意见(境内)标准无保留意见
TOP↑